{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:52:41Z","timestamp":1791208361531,"version":"4.1.0"},"reference-count":39,"publisher":"American Society for Microbiology","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100019533","name":"Moderna, Inc.","doi-asserted-by":"publisher","award":["GRO245623"],"award-info":[{"award-number":["GRO245623"]}],"id":[{"id":"10.13039\/100019533","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R37 AI147868"],"award-info":[{"award-number":["R37 AI147868"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Respiratory syncytial virus (RSV) continues to circulate at high levels despite the introduction of new monoclonal antibodies (mAbs) and vaccines targeting the pre-fusion F (pre-F) protein. We analyzed the viral genome sequences of 133 RSV clinical samples collected during the 2022\u20132023 and 2023\u20132024 seasons and selected representative isolates for phenotypic testing. We selected four RSV-A and four RSV-B replication-competent, sequence-verified stocks and then assessed them for replication kinetics\n                      <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                      and neutralization sensitivity with a panel of F-targeting mAbs and polyclonal sera using a rabbit vaccination model. Isolates retained sensitivity to all mAbs tested. We detected no mutations in mAb binding sites in the isolates tested. RSV-A isolates were slightly less susceptible to multiple mAbs than RSV-B isolates. Antigenic cartography revealed a separation of antibody responses by subtype: RSV-A isolates clustered together and aligned with lower neutralization by antibodies such as MPE8 and 101F, whereas RSV-B isolates formed a distinct cluster associated with higher mAb susceptibility. In a rabbit vaccination model, RSV-A-only sera efficiently neutralized all RSV-A isolates and the RSV-B1 reference strain but showed diminished activity against contemporary RSV-B isolates. RSV-B-only sera displayed balanced neutralization across both subtypes. Combined RSV-A + RSV-B immunization produced uniformly strong responses to all isolates, suggesting that multivalent exposure may overcome subtype-specific antibody polarization. Collectively, our results demonstrate consistent antigenic divergence of RSV subtypes and underscore the importance of using contemporary isolates, rather than legacy reference strains, to guide F-directed immunoprophylaxis and vaccine design.\n                    <\/jats:p>\n                    <jats:sec>\n                      <jats:title>\n                        <jats:bold>IMPORTANCE<\/jats:bold>\n                      <\/jats:title>\n                      <jats:p>Respiratory syncytial virus (RSV) remains a major cause of lower respiratory tract infections. Although new monoclonal antibodies (mAbs) and vaccines have been approved in recent years, the impact of circulating genetic diversity on these therapeutics is incompletely understood. In this study, we demonstrate how recent RSV isolates respond to a panel of mAbs and whether sera from rabbits vaccinated with mRNA vaccines effectively neutralize these isolates. We observe that RSV-A isolates are slightly more resistant to neutralization by mAbs than RSV-B isolates and that a bivalent vaccine elicits broader neutralizing responses than the monovalent vaccine. This study provides insights into how viral diversity may influence antibody-mediated protection and suggests that recent RSV-B isolates may respond differently from the laboratory-adapted strains commonly used in research, an important consideration for the design of next-generation vaccines and antibody therapeutics.<\/jats:p>\n                    <\/jats:sec>\n                  <\/jats:sec>","DOI":"10.1128\/jvi.01221-26","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:00:31Z","timestamp":1791205231000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":0,"title":["Subtype-specific differences in susceptibility to monoclonal antibodies and vaccines among contemporary RSV-A and RSV-B isolates"],"prefix":"10.1128","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3518-8491","authenticated-orcid":true,"given":"Paula Eillanny","family":"Silva Marinho","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/002pd6e78","id-type":"ROR","asserted-by":"publisher"}],"name":"Massachusetts General Hospital","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dibya","family":"Ghimire","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/002pd6e78","id-type":"ROR","asserted-by":"publisher"}],"name":"Massachusetts General Hospital","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Tsai Silva","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/002pd6e78","id-type":"ROR","asserted-by":"publisher"}],"name":"Massachusetts General Hospital","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Devlin","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/002pd6e78","id-type":"ROR","asserted-by":"publisher"}],"name":"Massachusetts General Hospital","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SunYoung","family":"Kwon","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/002pd6e78","id-type":"ROR","asserted-by":"publisher"}],"name":"Massachusetts General Hospital","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Adams","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/002pd6e78","id-type":"ROR","asserted-by":"publisher"}],"name":"Massachusetts General Hospital","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Jorquera","sequence":"additional","affiliation":[{"name":"Moderna TX Inc","place":["Cambridge, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Luban","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0464eyp60","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Massachusetts Chan Medical School","place":["Worcester, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2758-4005","authenticated-orcid":true,"given":"Jacob E.","family":"Lemieux","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/002pd6e78","id-type":"ROR","asserted-by":"publisher"}],"name":"Massachusetts General Hospital","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00478-0"},{"key":"e_1_3_5_3_2","unstructured":"Respiratory Syncytial Virus (RSV). 2026. Internet. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/respiratory-syncytial-virus-%28rsv%29. Retrieved 15 Apr 2026."},{"key":"e_1_3_5_4_2","unstructured":"CDC. 2026. About RSV. Internet. Respiratory syncytial virus infection (RSV). Available from: https:\/\/www.cdc.gov\/rsv\/about\/index.html. Retrieved 15 Apr 2026."},{"key":"e_1_3_5_5_2","unstructured":"Respiratory Syncytial Virus (RSV). 2026. Internet. National Institute of Allergy and Infectious Diseases. Available from: https:\/\/www.niaid.nih.gov\/diseases-conditions\/respiratory-syncytial-virus-rsv. Retrieved 10 Apr 2026."},{"key":"e_1_3_5_6_2","unstructured":"CDC. 2025. Preliminary estimates of RSV burden for 2024-2025. Internet. Respiratory syncytial virus infection (RSV). Available from: https:\/\/www.cdc.gov\/rsv\/php\/surveillance\/burden-estimates.html. Retrieved 20 Apr 2025."},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000952"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000001000"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00010-16"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-38919-1_4"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-024-01012-2"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1234914"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1243283"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202114035"},{"key":"e_1_3_5_15_2","unstructured":"Office of the Commissioner. 2024. FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine. Internet. U.S. Food and Drug Administration FDA. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-respiratory-syncytial-virus-rsv-vaccine. Retrieved 10 Apr 2026."},{"key":"e_1_3_5_16_2","unstructured":"Center for Biologics Evaluation Research. 2025. ABRYSVO. Internet. U.S. Food and Drug Administration FDA. Available from: https:\/\/www.fda.gov\/vaccines-blood-biologics\/abrysvo. Retrieved 10 Apr 2026."},{"key":"e_1_3_5_17_2","unstructured":"Center for Biologics Evaluation Research. 2025. MRESVIA Respiratory Syncytial Virus Vaccine mRNA (mRNA-1345). Internet. U.S. Food and Drug Administration FDA. Available from: https:\/\/www.fda.gov\/vaccines-blood-biologics\/vaccines\/mresvia. Retrieved 10 Apr 2026."},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2014-1665"},{"key":"e_1_3_5_19_2","unstructured":"Office of the Commissioner. 2024. FDA approves new drug to prevent RSV in babies and toddlers. Internet. U.S. Food and Drug Administration FDA. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-new-drug-prevent-rsv-babies-and-toddlers. Retrieved 10 Apr 2026."},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaj1928"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2502984"},{"key":"e_1_3_5_22_2","unstructured":"Merck. 2025. U.S. FDA Approves Merck\u2019s ENFLONSIATM (clesrovimab-cfor) for prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in infants born during or entering their first RSV season. Internet. Merck.Com. Available from: https:\/\/www.merck.com\/news\/u-s-fda-approves-mercks-enflonsia-clesrovimab-cfor-for-prevention-of-respiratory-syncytial-virus-rsv-lower-respiratory-tract-disease-in-infants-born-during-or-entering-their-fir\/. Retrieved 10 Apr 2026."},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2216153"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2904.221834"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid3011.241000"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.3390\/v11111031"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-8-43"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa951"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.00860-24"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy189"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00531-25"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01900-22"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adg6050"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0180623"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.3.817-820.2002"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/immhor\/vlag006"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.11.012"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2024.05.019"},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.1098\/rsta.2015.0202"},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1097211"}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/jvi.01221-26","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/jvi.01221-26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:00:43Z","timestamp":1791205243000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/jvi.01221-26"}},"subtitle":[],"editor":[{"given":"Ryan A.","family":"Langlois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":39,"alternative-id":["10.1128\/jvi.01221-26"],"URL":"https:\/\/doi.org\/10.1128\/jvi.01221-26","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"assertion":[{"value":"2026-09-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01221-26"}}